Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst

Cell & Gene: The Podcast

English - December 21, 2023 09:00 - 13 minutes - 9.48 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Overcoming the Limitations of CAR T-Cell Therapy with Vittoria Bio's Nick Siciliano, Ph.D.

Next Episode: 4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.

For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Greg navigated the event as a first-timer attending Meeting on the Mesa.